nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—CYP2D6—Methimazole—Graves' disease	0.411	0.611	CbGbCtD
Lisuride—CYP3A4—Methimazole—Graves' disease	0.261	0.389	CbGbCtD
Lisuride—DRD5—eyelid—Graves' disease	0.154	0.589	CbGeAlD
Lisuride—HTR1D—eye—Graves' disease	0.0103	0.0393	CbGeAlD
Lisuride—HTR1D—connective tissue—Graves' disease	0.00993	0.0379	CbGeAlD
Lisuride—ADRB1—connective tissue—Graves' disease	0.00965	0.0368	CbGeAlD
Lisuride—DRD2—eye—Graves' disease	0.00776	0.0296	CbGeAlD
Lisuride—ADRB1—adipose tissue—Graves' disease	0.00741	0.0282	CbGeAlD
Lisuride—HTR2B—adipose tissue—Graves' disease	0.00709	0.027	CbGeAlD
Lisuride—HTR2B—thyroid gland—Graves' disease	0.00614	0.0234	CbGeAlD
Lisuride—ADRA2A—connective tissue—Graves' disease	0.0058	0.0221	CbGeAlD
Lisuride—DRD2—pituitary gland—Graves' disease	0.00576	0.022	CbGeAlD
Lisuride—ADRA2C—pituitary gland—Graves' disease	0.0056	0.0214	CbGeAlD
Lisuride—ADRA2C—adipose tissue—Graves' disease	0.00558	0.0213	CbGeAlD
Lisuride—HTR2A—eye—Graves' disease	0.00512	0.0195	CbGeAlD
Lisuride—HTR2A—connective tissue—Graves' disease	0.00493	0.0188	CbGeAlD
Lisuride—ADRA2A—pituitary gland—Graves' disease	0.00447	0.0171	CbGeAlD
Lisuride—ADRA2A—adipose tissue—Graves' disease	0.00445	0.017	CbGeAlD
Lisuride—ADRA2A—thyroid gland—Graves' disease	0.00385	0.0147	CbGeAlD
Lisuride—HTR2A—pituitary gland—Graves' disease	0.0038	0.0145	CbGeAlD
Lisuride—DRD5—GPCR ligand binding—TSHR—Graves' disease	0.000383	0.00587	CbGpPWpGaD
Lisuride—HTR1B—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000378	0.00578	CbGpPWpGaD
Lisuride—DRD4—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000372	0.00569	CbGpPWpGaD
Lisuride—HTR2B—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000355	0.00543	CbGpPWpGaD
Lisuride—DRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000335	0.00512	CbGpPWpGaD
Lisuride—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00033	0.00505	CbGpPWpGaD
Lisuride—DRD3—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00033	0.00505	CbGpPWpGaD
Lisuride—DRD5—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000325	0.00498	CbGpPWpGaD
Lisuride—HTR1D—G alpha (i) signalling events—CXCL10—Graves' disease	0.000313	0.0048	CbGpPWpGaD
Lisuride—HTR1B—G alpha (i) signalling events—CXCL10—Graves' disease	0.000307	0.0047	CbGpPWpGaD
Lisuride—DRD4—G alpha (i) signalling events—CXCL10—Graves' disease	0.000302	0.00462	CbGpPWpGaD
Lisuride—ADRB1—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000301	0.0046	CbGpPWpGaD
Lisuride—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000298	0.00456	CbGpPWpGaD
Lisuride—HTR1D—GPCR ligand binding—TSHR—Graves' disease	0.000294	0.0045	CbGpPWpGaD
Lisuride—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000288	0.0044	CbGpPWpGaD
Lisuride—HTR1B—GPCR ligand binding—TSHR—Graves' disease	0.000288	0.0044	CbGpPWpGaD
Lisuride—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000286	0.00438	CbGpPWpGaD
Lisuride—DRD4—GPCR ligand binding—TSHR—Graves' disease	0.000283	0.00433	CbGpPWpGaD
Lisuride—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000278	0.00426	CbGpPWpGaD
Lisuride—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000274	0.00419	CbGpPWpGaD
Lisuride—HTR2B—GPCR ligand binding—TSHR—Graves' disease	0.00027	0.00414	CbGpPWpGaD
Lisuride—DRD3—G alpha (i) signalling events—CXCL10—Graves' disease	0.000268	0.00411	CbGpPWpGaD
Lisuride—DRD4—Circadian rythm related genes—FAS—Graves' disease	0.000263	0.00403	CbGpPWpGaD
Lisuride—DRD1—GPCR ligand binding—TSHR—Graves' disease	0.000255	0.0039	CbGpPWpGaD
Lisuride—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000253	0.00387	CbGpPWpGaD
Lisuride—DRD3—GPCR ligand binding—TSHR—Graves' disease	0.000251	0.00385	CbGpPWpGaD
Lisuride—ADRA1D—GPCR ligand binding—TSHR—Graves' disease	0.000251	0.00385	CbGpPWpGaD
Lisuride—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000249	0.00381	CbGpPWpGaD
Lisuride—HTR2A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000249	0.0038	CbGpPWpGaD
Lisuride—DRD5—GPCR ligand binding—CXCL10—Graves' disease	0.000248	0.00379	CbGpPWpGaD
Lisuride—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000244	0.00374	CbGpPWpGaD
Lisuride—ADRA2B—G alpha (i) signalling events—CXCL10—Graves' disease	0.000242	0.00371	CbGpPWpGaD
Lisuride—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.00024	0.00368	CbGpPWpGaD
Lisuride—DRD1—Circadian rythm related genes—FAS—Graves' disease	0.000237	0.00363	CbGpPWpGaD
Lisuride—HTR1A—G alpha (i) signalling events—CXCL10—Graves' disease	0.000234	0.00358	CbGpPWpGaD
Lisuride—DRD3—Circadian rythm related genes—FAS—Graves' disease	0.000234	0.00358	CbGpPWpGaD
Lisuride—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000229	0.00351	CbGpPWpGaD
Lisuride—ADRB1—GPCR ligand binding—TSHR—Graves' disease	0.000229	0.00351	CbGpPWpGaD
Lisuride—ADRA2B—GPCR ligand binding—TSHR—Graves' disease	0.000227	0.00347	CbGpPWpGaD
Lisuride—ADRA2C—G alpha (i) signalling events—CXCL10—Graves' disease	0.000226	0.00346	CbGpPWpGaD
Lisuride—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000226	0.00346	CbGpPWpGaD
Lisuride—HTR1A—GPCR ligand binding—TSHR—Graves' disease	0.000219	0.00335	CbGpPWpGaD
Lisuride—HTR2C—GPCR ligand binding—TSHR—Graves' disease	0.000218	0.00334	CbGpPWpGaD
Lisuride—DRD5—GPCR downstream signaling—TSHR—Graves' disease	0.000217	0.00332	CbGpPWpGaD
Lisuride—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000216	0.00331	CbGpPWpGaD
Lisuride—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000213	0.00326	CbGpPWpGaD
Lisuride—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000213	0.00326	CbGpPWpGaD
Lisuride—ADRA2C—GPCR ligand binding—TSHR—Graves' disease	0.000212	0.00324	CbGpPWpGaD
Lisuride—ADRA1B—GPCR ligand binding—TSHR—Graves' disease	0.000209	0.00319	CbGpPWpGaD
Lisuride—DRD2—G alpha (i) signalling events—CXCL10—Graves' disease	0.000205	0.00314	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—TSHR—Graves' disease	0.000197	0.00301	CbGpPWpGaD
Lisuride—ADRA2B—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000194	0.00298	CbGpPWpGaD
Lisuride—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000194	0.00297	CbGpPWpGaD
Lisuride—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000193	0.00295	CbGpPWpGaD
Lisuride—DRD2—GPCR ligand binding—TSHR—Graves' disease	0.000192	0.00294	CbGpPWpGaD
Lisuride—HTR1D—GPCR ligand binding—CXCL10—Graves' disease	0.00019	0.00291	CbGpPWpGaD
Lisuride—HTR2A—GPCR ligand binding—TSHR—Graves' disease	0.000189	0.0029	CbGpPWpGaD
Lisuride—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000186	0.00285	CbGpPWpGaD
Lisuride—HTR1B—GPCR ligand binding—CXCL10—Graves' disease	0.000186	0.00284	CbGpPWpGaD
Lisuride—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000185	0.00283	CbGpPWpGaD
Lisuride—ADRA2A—G alpha (i) signalling events—CXCL10—Graves' disease	0.000184	0.00281	CbGpPWpGaD
Lisuride—DRD4—GPCR ligand binding—CXCL10—Graves' disease	0.000183	0.0028	CbGpPWpGaD
Lisuride—ADRA2C—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000182	0.00278	CbGpPWpGaD
Lisuride—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.00018	0.00275	CbGpPWpGaD
Lisuride—DRD2—Circadian rythm related genes—FAS—Graves' disease	0.000179	0.00274	CbGpPWpGaD
Lisuride—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000177	0.00271	CbGpPWpGaD
Lisuride—HTR2B—GPCR ligand binding—CXCL10—Graves' disease	0.000175	0.00267	CbGpPWpGaD
Lisuride—ADRA2A—GPCR ligand binding—TSHR—Graves' disease	0.000172	0.00264	CbGpPWpGaD
Lisuride—HTR1D—GPCR downstream signaling—TSHR—Graves' disease	0.000166	0.00254	CbGpPWpGaD
Lisuride—DRD1—GPCR ligand binding—CXCL10—Graves' disease	0.000165	0.00252	CbGpPWpGaD
Lisuride—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000163	0.0025	CbGpPWpGaD
Lisuride—HTR1B—GPCR downstream signaling—TSHR—Graves' disease	0.000163	0.00249	CbGpPWpGaD
Lisuride—ADRA1D—GPCR ligand binding—CXCL10—Graves' disease	0.000162	0.00249	CbGpPWpGaD
Lisuride—DRD3—GPCR ligand binding—CXCL10—Graves' disease	0.000162	0.00249	CbGpPWpGaD
Lisuride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000161	0.00246	CbGpPWpGaD
Lisuride—DRD4—GPCR downstream signaling—TSHR—Graves' disease	0.00016	0.00245	CbGpPWpGaD
Lisuride—HTR2B—GPCR downstream signaling—TSHR—Graves' disease	0.000153	0.00234	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—TSHR—Graves' disease	0.000151	0.00231	CbGpPWpGaD
Lisuride—ADRB1—GPCR ligand binding—CXCL10—Graves' disease	0.000148	0.00227	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—TSHR—Graves' disease	0.000148	0.00226	CbGpPWpGaD
Lisuride—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000148	0.00226	CbGpPWpGaD
Lisuride—ADRA2B—GPCR ligand binding—CXCL10—Graves' disease	0.000147	0.00224	CbGpPWpGaD
Lisuride—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000146	0.00224	CbGpPWpGaD
Lisuride—HTR1A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000146	0.00223	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—TSHR—Graves' disease	0.000145	0.00222	CbGpPWpGaD
Lisuride—DRD1—GPCR downstream signaling—TSHR—Graves' disease	0.000144	0.0022	CbGpPWpGaD
Lisuride—ADRA1D—GPCR downstream signaling—TSHR—Graves' disease	0.000142	0.00217	CbGpPWpGaD
Lisuride—DRD3—GPCR downstream signaling—TSHR—Graves' disease	0.000142	0.00217	CbGpPWpGaD
Lisuride—HTR1A—GPCR ligand binding—CXCL10—Graves' disease	0.000142	0.00217	CbGpPWpGaD
Lisuride—HTR2C—GPCR ligand binding—CXCL10—Graves' disease	0.000141	0.00216	CbGpPWpGaD
Lisuride—DRD5—GPCR downstream signaling—CXCL10—Graves' disease	0.00014	0.00214	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—TSHR—Graves' disease	0.000139	0.00212	CbGpPWpGaD
Lisuride—ADRA2C—GPCR ligand binding—CXCL10—Graves' disease	0.000137	0.0021	CbGpPWpGaD
Lisuride—ADRA1B—GPCR ligand binding—CXCL10—Graves' disease	0.000135	0.00206	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—TSHR—Graves' disease	0.000131	0.002	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—TSHR—Graves' disease	0.000129	0.00198	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—TSHR—Graves' disease	0.000129	0.00197	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—TSHR—Graves' disease	0.000129	0.00197	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—TSHR—Graves' disease	0.000128	0.00196	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—CXCL10—Graves' disease	0.000127	0.00195	CbGpPWpGaD
Lisuride—HTR2A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000126	0.00193	CbGpPWpGaD
Lisuride—DRD2—GPCR ligand binding—CXCL10—Graves' disease	0.000124	0.0019	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—TSHR—Graves' disease	0.000124	0.0019	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—TSHR—Graves' disease	0.000123	0.00189	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—GC—Graves' disease	0.000122	0.00187	CbGpPWpGaD
Lisuride—HTR2A—GPCR ligand binding—CXCL10—Graves' disease	0.000122	0.00187	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—TSHR—Graves' disease	0.00012	0.00183	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—TSHR—Graves' disease	0.000118	0.0018	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—TSHR—Graves' disease	0.000118	0.0018	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—TSHR—Graves' disease	0.000116	0.00178	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—TSHR—Graves' disease	0.000116	0.00178	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—TSHR—Graves' disease	0.000112	0.00172	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—TSHR—Graves' disease	0.000112	0.00171	CbGpPWpGaD
Lisuride—ADRA2A—GPCR ligand binding—CXCL10—Graves' disease	0.000111	0.0017	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—TSHR—Graves' disease	0.000109	0.00167	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—TSHR—Graves' disease	0.000109	0.00166	CbGpPWpGaD
Lisuride—HTR1D—GPCR downstream signaling—CXCL10—Graves' disease	0.000107	0.00164	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—TSHR—Graves' disease	0.000107	0.00164	CbGpPWpGaD
Lisuride—DRD5—GPCR downstream signaling—IL2RA—Graves' disease	0.000107	0.00164	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—TSHR—Graves' disease	0.000107	0.00164	CbGpPWpGaD
Lisuride—HTR1A—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000106	0.00162	CbGpPWpGaD
Lisuride—HTR1B—GPCR downstream signaling—CXCL10—Graves' disease	0.000105	0.00161	CbGpPWpGaD
Lisuride—DRD4—GPCR downstream signaling—CXCL10—Graves' disease	0.000103	0.00158	CbGpPWpGaD
Lisuride—ADRA2B—Hemostasis—IL2RA—Graves' disease	0.0001	0.00153	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—GC—Graves' disease	9.94e-05	0.00152	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—TSHR—Graves' disease	9.87e-05	0.00151	CbGpPWpGaD
Lisuride—HTR2B—GPCR downstream signaling—CXCL10—Graves' disease	9.87e-05	0.00151	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—CXCL10—Graves' disease	9.74e-05	0.00149	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—TSHR—Graves' disease	9.73e-05	0.00149	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—IL2RA—Graves' disease	9.72e-05	0.00149	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—TSHR—Graves' disease	9.71e-05	0.00149	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—CXCL10—Graves' disease	9.54e-05	0.00146	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—CXCL10—Graves' disease	9.39e-05	0.00144	CbGpPWpGaD
Lisuride—ADRA2C—Hemostasis—IL2RA—Graves' disease	9.36e-05	0.00143	CbGpPWpGaD
Lisuride—DRD1—GPCR downstream signaling—CXCL10—Graves' disease	9.3e-05	0.00142	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—B3GNT2—Graves' disease	9.28e-05	0.00142	CbGpPWpGaD
Lisuride—ADRA1D—GPCR downstream signaling—CXCL10—Graves' disease	9.18e-05	0.00141	CbGpPWpGaD
Lisuride—DRD3—GPCR downstream signaling—CXCL10—Graves' disease	9.18e-05	0.00141	CbGpPWpGaD
Lisuride—HTR2A—SIDS Susceptibility Pathways—TNF—Graves' disease	9.15e-05	0.0014	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—CXCL10—Graves' disease	8.96e-05	0.00137	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TSHR—Graves' disease	8.9e-05	0.00136	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—TSHR—Graves' disease	8.84e-05	0.00135	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TSHR—Graves' disease	8.72e-05	0.00133	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TSHR—Graves' disease	8.58e-05	0.00131	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—CXCL10—Graves' disease	8.45e-05	0.00129	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—CXCL10—Graves' disease	8.36e-05	0.00128	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—CXCL10—Graves' disease	8.34e-05	0.00128	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—CXCL10—Graves' disease	8.34e-05	0.00128	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—CXCL10—Graves' disease	8.29e-05	0.00127	CbGpPWpGaD
Lisuride—HTR1D—GPCR downstream signaling—IL2RA—Graves' disease	8.2e-05	0.00125	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TSHR—Graves' disease	8.19e-05	0.00125	CbGpPWpGaD
Lisuride—HTR1B—GPCR downstream signaling—IL2RA—Graves' disease	8.03e-05	0.00123	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—CXCL10—Graves' disease	8e-05	0.00122	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—CXCL10—Graves' disease	7.96e-05	0.00122	CbGpPWpGaD
Lisuride—DRD4—GPCR downstream signaling—IL2RA—Graves' disease	7.9e-05	0.00121	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—CXCL10—Graves' disease	7.74e-05	0.00118	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TSHR—Graves' disease	7.72e-05	0.00118	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TSHR—Graves' disease	7.62e-05	0.00117	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TSHR—Graves' disease	7.62e-05	0.00117	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—CXCL10—Graves' disease	7.62e-05	0.00117	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—IL2RA—Graves' disease	7.61e-05	0.00116	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—CXCL10—Graves' disease	7.6e-05	0.00116	CbGpPWpGaD
Lisuride—HTR2B—GPCR downstream signaling—IL2RA—Graves' disease	7.54e-05	0.00115	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—B3GNT2—Graves' disease	7.53e-05	0.00115	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—CXCL10—Graves' disease	7.53e-05	0.00115	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—CXCL10—Graves' disease	7.51e-05	0.00115	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—IL2RA—Graves' disease	7.44e-05	0.00114	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—IL2RA—Graves' disease	7.29e-05	0.00112	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—CXCL10—Graves' disease	7.27e-05	0.00111	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—CXCL10—Graves' disease	7.23e-05	0.00111	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—IL2RA—Graves' disease	7.17e-05	0.0011	CbGpPWpGaD
Lisuride—DRD1—GPCR downstream signaling—IL2RA—Graves' disease	7.11e-05	0.00109	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—CXCL10—Graves' disease	7.03e-05	0.00108	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—CXCL10—Graves' disease	7.02e-05	0.00108	CbGpPWpGaD
Lisuride—DRD3—GPCR downstream signaling—IL2RA—Graves' disease	7.02e-05	0.00107	CbGpPWpGaD
Lisuride—ADRA1D—GPCR downstream signaling—IL2RA—Graves' disease	7.02e-05	0.00107	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TSHR—Graves' disease	6.94e-05	0.00106	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—CXCL10—Graves' disease	6.92e-05	0.00106	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—CXCL10—Graves' disease	6.91e-05	0.00106	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TSHR—Graves' disease	6.88e-05	0.00105	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—IL2RA—Graves' disease	6.85e-05	0.00105	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TSHR—Graves' disease	6.64e-05	0.00102	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TSHR—Graves' disease	6.61e-05	0.00101	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GC—Graves' disease	6.48e-05	0.000992	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—IL2RA—Graves' disease	6.46e-05	0.000988	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TSHR—Graves' disease	6.43e-05	0.000984	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—IL2RA—Graves' disease	6.39e-05	0.000978	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—CXCL10—Graves' disease	6.38e-05	0.000976	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—IL2RA—Graves' disease	6.37e-05	0.000975	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—IL2RA—Graves' disease	6.37e-05	0.000975	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—IL2RA—Graves' disease	6.33e-05	0.00097	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TSHR—Graves' disease	6.33e-05	0.000968	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—CXCL10—Graves' disease	6.29e-05	0.000962	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—CXCL10—Graves' disease	6.28e-05	0.000961	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—IL2RA—Graves' disease	6.12e-05	0.000936	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—IL2RA—Graves' disease	6.08e-05	0.000931	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—IL2RA—Graves' disease	5.92e-05	0.000906	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TSHR—Graves' disease	5.83e-05	0.000893	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—IL2RA—Graves' disease	5.82e-05	0.000891	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—IL2RA—Graves' disease	5.81e-05	0.000889	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CXCL10—Graves' disease	5.75e-05	0.000881	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—IL2RA—Graves' disease	5.75e-05	0.00088	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—IL2RA—Graves' disease	5.74e-05	0.000879	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TSHR—Graves' disease	5.74e-05	0.000878	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—CXCL10—Graves' disease	5.71e-05	0.000874	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CXCL10—Graves' disease	5.63e-05	0.000862	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—IL2RA—Graves' disease	5.55e-05	0.00085	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CXCL10—Graves' disease	5.54e-05	0.000849	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—IL2RA—Graves' disease	5.52e-05	0.000846	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—IL2RA—Graves' disease	5.37e-05	0.000822	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—IL2RA—Graves' disease	5.37e-05	0.000822	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CXCL10—Graves' disease	5.29e-05	0.00081	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—IL2RA—Graves' disease	5.29e-05	0.000809	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—IL2RA—Graves' disease	5.28e-05	0.000809	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TSHR—Graves' disease	5.22e-05	0.000799	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CXCL10—Graves' disease	4.99e-05	0.000764	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CXCL10—Graves' disease	4.92e-05	0.000754	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CXCL10—Graves' disease	4.92e-05	0.000754	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—B3GNT2—Graves' disease	4.91e-05	0.000751	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—IL2RA—Graves' disease	4.88e-05	0.000746	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—IL2RA—Graves' disease	4.81e-05	0.000736	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—IL2RA—Graves' disease	4.8e-05	0.000734	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CXCL10—Graves' disease	4.49e-05	0.000687	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CXCL10—Graves' disease	4.45e-05	0.00068	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL2RA—Graves' disease	4.4e-05	0.000673	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL2RA—Graves' disease	4.36e-05	0.000668	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL2RA—Graves' disease	4.31e-05	0.000659	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CXCL10—Graves' disease	4.29e-05	0.000657	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CXCL10—Graves' disease	4.27e-05	0.000654	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL2RA—Graves' disease	4.24e-05	0.000649	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GC—Graves' disease	4.24e-05	0.000648	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CXCL10—Graves' disease	4.15e-05	0.000636	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CXCL10—Graves' disease	4.09e-05	0.000626	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL2RA—Graves' disease	4.05e-05	0.000619	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL2RA—Graves' disease	3.81e-05	0.000584	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CXCL10—Graves' disease	3.77e-05	0.000577	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL2RA—Graves' disease	3.76e-05	0.000576	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL2RA—Graves' disease	3.76e-05	0.000576	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CXCL10—Graves' disease	3.71e-05	0.000568	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL2RA—Graves' disease	3.43e-05	0.000525	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL2RA—Graves' disease	3.4e-05	0.00052	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CXCL10—Graves' disease	3.37e-05	0.000516	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL2RA—Graves' disease	3.28e-05	0.000502	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL2RA—Graves' disease	3.26e-05	0.000499	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—B3GNT2—Graves' disease	3.21e-05	0.000491	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL2RA—Graves' disease	3.17e-05	0.000486	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL2RA—Graves' disease	3.12e-05	0.000478	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL2RA—Graves' disease	2.88e-05	0.000441	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL2RA—Graves' disease	2.83e-05	0.000434	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL2RA—Graves' disease	2.58e-05	0.000395	CbGpPWpGaD
